Nguyen Van Dinh, PhD, MD
Director Head of Allergy/Autoimmunology
Associate Professor
Biography
Assoc. Prof. Nguyen Van Dinh has over 15 years of experience in Allergy, Clinical Immunology, and medical education. He graduated the Degree of Medical doctor at Hanoi Medical University (HMU) in 2007, then he entered the residency program in Allergy and Clinical Immunology in 2011 with excellent standings. Awarded an Australia Awards Scholarship, he earned his PhD in Medicine at the University of Sydney in 2018. Dr. Dinh has held clinical placements at major teaching hospitals in Australia and the U.S. and completed a Health Professional Education program at the University of Pennsylvania in 2023.
Currently, he serves as Director of the Vinmec – VinUni Institute of Immunology and the Center of Excellence in Allergy and Clinical Immunology at Vinmec Times City. He is also affiliated with VinUniversity and Penn State College of Medicine. A member of key international organizations like AAAAI, EACCI, WAO, and APAACI, he also serves on several guideline panels and committees (Skin Allergy (WAO) and Drug Hypersensitivity (APAACI).
A/Prof. Nguyen’s research focuses on pharmacogenomics in drug hypersensitivity, with notable contributions to HLA associations with severe cutaneous adverse drug reactions (SCARs). He has published one edited book, five book chapters, 34 papers in Vietnamese journals, and 31 ISI/SCOPUS-indexed articles, garnering over 700 citations and an H-index of 12. He is an active reviewer for high-impact journals such as Allergy Journal, The Pharmacogenomics Journal and principal investigator on projects in pharmacogenomics, immunotherapy, hereditary angioedema, and atopic dermatitis.
Recognized with numerous awards, including the APAACI Best Paper Award (2013), Chairman’s Award of HocMai Foundation, University of Sydney (2016), The Best Article of the Year on Asia Pacific Allergy Journal (2018), APSR Clinical Allergy and Immunology Assembly Award (2019) and Internal Medicine Residency Program Excellent Teacher Award, VinUniversity (2021). Dr. Nguyen has successfully supervised 5 master students, 2 residents and 1 PhD student. He has been met the standards of Associate Professor, certified by the Vietnam State Council for Professorship.
Allergy, Clinical Immunology
Description of 3 cases in Vietnam of aspirin desensitization in patients with coronary artery disease and coexisting aspirin hypersensitivity. World Allergy Organization Journal. 2012;5(11):170–173. https://doi.org/10.1016/S1939-4551(19)30397-7
HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese. Asia Pacific Allergy. 2015;5(2):68–77. (Synapse record).
Validation of a rapid test for HLA-B*58:01/57:01 allele screening to detect individuals at risk for drug-induced hypersensitivity. Pharmacogenomics. 2016;17(5):473–480. https://doi.org/10.2217/pgs.15.185
Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine-induced Stevens–Johnson syndrome/Toxic Epidermal Necrolysis in individuals of Asian ancestry. Human Immunology. 2016;77(12):1140–1146. https://doi.org/10.1016/S0198-8859(16)30419-0
Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B*58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions. Allergy, Asthma & Immunology Research. 2017;9(1):79–84. (Synapse record)
A novel multiplex polymerase chain reaction assay for detection of both HLA-A31:01/HLA-B15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions. HLA: Immune Response Genetics. 2017;90(6):335–342. https://doi.org/10.1111/tan.13143
Developing pharmacogenetic screening methods for an emergent country: Vietnam. World Allergy Organization Journal. 2019;12(5):1–10. https://doi.org/10.1016/S1939-4551(19)30666-0
Human leukocyte antigen-associated severe cutaneous adverse drug reactions: from bedside to bench and beyond. Asia Pacific Allergy. 2019;9(3):e20, 1–24. (Synapse record)
Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention. Annals of Allergy, Asthma & Immunology. 2019;123(5):483–487. https://doi.org/10.1016/j.anai.2019.10.006
Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report. BMC Endocrine Disorders. 2019;19:121. https://doi.org/10.1186/s12902-019-0451-7
Gene expression profiling in allopurinol-induced severe cutaneous adverse reactions in Vietnamese. Pharmacogenomics. 2020;21(14):985–994. https://doi.org/10.2217/pgs-2020-0014
Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese. Pharmacogenomics. 2020;21(14):1–12. https://doi.org/10.2217/pgs-2019-0146
Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions. Pharmacogenomics and Personalized Medicine. 2021;14:61–75. (PMC full text) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812041/
A Novel Allele-Specific PCR Protocol for the Detection of the HLA-C*03:02 Allele, a Pharmacogenetic Marker, in Vietnamese Kinh People. The Application of Clinical Genetics. 2021;14:27–35. https://doi.org/10.2147/TACG.S278652
A novel nested allele-specific PCR protocol for the detection of the HLA-A*33:03, a SCAR-associated allele, in Vietnamese people. Asian Pacific Journal of Allergy and Immunology. 2021;[AP-201120-1000]. (PubMed record) PMID: 33865300
Utility of skin testing in assessment of post-AZD1222 vaccine (AstraZeneca) allergic reactions: case series in Vietnam. Asia Pacific Allergy. 2021;11(4):e40:1–6. (PMC full text) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563096/
Allopurinol-induced severe cutaneous adverse reactions in Vietnamese: the role of HLA alleles and other risk factors. Pharmacogenomics. 2022;23(5):303–313. https://doi.org/10.2217/pgs-2021-0156
The utility of surrogate markers in predicting HLA alleles associated with adverse drug reactions in Vietnamese. Asian Pacific Journal of Allergy and Immunology. 2022;40(2):134–141. doi:10.12932/AP-170219-0493. PMID: 31421661
The international WAO/EAACI guideline for the management of hereditary angioedema — The 2021 revision
1. The Best Paper Award at the Asia Pacific Allergy and Clinical Immunology Conference, 2013, Taiwan.
2. Chair’s Man Award from the Hoc Mai Foundation, University of Sydney, for contributions to research and scientific development.
3. Third Prize “Đặng Văn Ngữ” of Hanoi Medical University, 2017, for faculty members with publications in high-impact journals.
4. Best Paper of the Year Award, Asia Pacific Allergy Journal, 2018.
5. Favorite Visiting Lecturer Award, Hanoi Medical University, 2019.
6. APSR Clinical Allergy & Immunology Assembly Education Award at the 24th Congress of the Asian Pacific Society of Respirology, 2019.
7. Internal Medicine Residency Program Excellent Teacher Award, Academic Year 2020–2021.
8. Best Presenter Award at the Annual Scientific Conference of the Vietnam Rheumatology Association, May 20, 2023.
9. Most Downloaded Article Award for the 12 months following publication in Allergy journal (January 1, 2022 – December 31, 2022).
10. Certification of the Allergy – Clinical Immunology Center achieving ADCARE 2023, UCARE 2024, and WAO 2025.
11. Certification of appointment as Associate Professor, 2024.